Patent · US Expired

Dolastatin 10 derivatives

US6737409B2 · kind B2 · utility

3Cited by
0References
52Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 15, 2002
Grant dateMay 18, 2004
Priority date
Expiry dateJul 15, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K5/0205
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel anti-tumor compounds of formula, are disclosed. Also disclosed are pharmaceutical compositions comprising compounds of formula (I), the use of compounds of formula (I) for the treatment of cancer, and processes for the preparation of compounds (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.